Related Experiment Videos

Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome

Jesus M Salvador1, M Christine Hollander, Anh Thu Nguyen

  • 1Gene Response Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Immunity
|April 24, 2002
PubMed

Insights

Growth arrest and DNA damage-inducible (Gadd45a) and cyclin-dependent kinase inhibitor 1 (p21) genes regulate T cell proliferation and prevent autoimmune disease. Their absence accelerates autoimmunity, highlighting their distinct immune functions.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • The p53-inducible genes Gadd45a and p21 are critical regulators of cellular processes.
  • Their specific roles in immune system regulation and autoimmunity remain incompletely understood.

Purpose of the Study:

  • To investigate the biological functions of Gadd45a and p21 within the immune system.
  • To determine their involvement in T cell proliferation and the development of autoimmune diseases.

Main Methods:

  • Utilized gene-knockout mouse models (Gadd45a(-/-) and p21(-/-)) to study immune responses.
  • Analyzed T cell activation thresholds and proliferation following T cell receptor stimulation.
  • Assessed autoimmune disease development, including autoantibody production and organ pathology.

Main Results:

  • Gadd45a acts as a negative regulator of T cell proliferation, with Gadd45a(-/-) T cells exhibiting increased activation and proliferation.
  • Gadd45a(-/-) mice develop a lupus-like autoimmune disease characterized by autoantibodies, hematological disorders, and glomerulonephritis.
  • The combined absence of Gadd45a and p21 significantly accelerates autoimmune disease onset compared to single-gene disruptions, indicating nonredundant roles.

Conclusions:

  • Gadd45a and p21 play crucial, nonredundant roles in maintaining immune homeostasis.
  • These genes are essential for preventing the development of systemic autoimmunity.
  • Dysregulation of Gadd45a and p21 contributes to autoimmune pathogenesis, offering potential therapeutic targets.

Related Concept Videos